Kamira Maharaj

发表

HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model

J. Pinilla-Ibarz, Simon S. Jones, S. Quayle, 2020, Frontiers in Immunology.

Regulatory T cells (Tregs) in lymphoid malignancies and the impact of novel therapies

J. Pinilla-Ibarz, E. Sahakian, Kamira Maharaj, 2022, Frontiers in Immunology.

Modulation of T Cell Compartment in a Preclinical CLL Murine Model By a Selective PI3K Delta Inhibitor, TGR-1202

J. Pinilla-Ibarz, E. Sahakian, Mibel Pabón-Saldaña, 2016 .

Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology

Sheng Wei, E. Seto, J. Pinilla-Ibarz, 2017, Journal of leukocyte biology.

The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells.

J. Cleveland, J. Pinilla-Ibarz, W. Roush, 2020, Blood advances.

Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia.

J. Pinilla-Ibarz, E. Sahakian, Kamira Maharaj, 2017, Blood advances.

Differential Regulation of T Cells By PI3K Delta Inhibitors in a CLL Murine Model

J. Pinilla-Ibarz, E. Sahakian, Mibel Pabón-Saldaña, 2017 .

Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia.

J. Pinilla-Ibarz, Simon S. Jones, E. Sotomayor, 2018, Blood advances.

Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma.

Idhaliz Flores, J. Conejo-Garcia, Patrick Innamarato, 2023, Gynecologic oncology.

Emerging role of BCR signaling inhibitors in immunomodulation of chronic lymphocytic leukemia.

J. Pinilla-Ibarz, E. Sahakian, Kamira Maharaj, 2017, Blood advances.